pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 30·1 min read
save

Half of U.S. states file lawsuits challenging Medicaid work-requirement rules

Jun 30, 2026·read at STAT ↗RegulatoryNegative

A coalition of states has filed legal challenges against recent Medicaid work‑requirement policies, arguing that the rules threaten access to health coverage for low‑income residents.

The lawsuits, filed in multiple federal courts, claim that the requirements conflict with federal law and could lead to loss of benefits for vulnerable populations. State officials say the policies were imposed without adequate justification and place undue burdens on patients.

In a separate health‑policy update, the FDA disclosed eight new members for a peptide advisory panel. Reporters noted that most of the appointees have ties to companies that produce or prescribe peptide therapies, raising concerns about potential conflicts of interest in future regulatory decisions.

Both stories highlight ongoing tensions between regulators, industry stakeholders, and public‑policy makers as they navigate the balance between innovation, oversight, and patient access.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Half of states sue over Medicaid work requirements”

read at STAT ↗
1,271 words · retrieved Jul 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COEli Lilly and CoLILLYNOVONovo Nordisk IncWashington University School of Medicine
drugs
Coronavirus Disease 2019 (COVID-19) vaccineCoronavirus Disease 2019 (COVID-19) vaccine 1Obesityinfluenza vaccine
topics
Peptide Therapeutic6Vaccines6Psychiatry & CNS3Vaccine2CardiologyObesityOncology

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Sep 286 immunology targets to sustain a mammoth I&I marketBioSpace
  • Aug 26Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealedBioSpace
  • Dec 22Fierce Biotech Fundraising Tracker '26: Matchpoint makes $150M; KymaThera corrals $80MFierce Biotech
  • 1d agoCaribou layoffs could wipe out 90% of staffBioSpace